Matches in Wikidata for { <http://www.wikidata.org/entity/Q90593938> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- Q90593938 description "article scientifique publié en 2018" @default.
- Q90593938 description "artículu científicu espublizáu n'avientu de 2018" @default.
- Q90593938 description "im Dezember 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90593938 description "scientific article published on 14 December 2018" @default.
- Q90593938 description "wetenschappelijk artikel" @default.
- Q90593938 description "наукова стаття, опублікована в грудні 2018" @default.
- Q90593938 name "Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10" @default.
- Q90593938 name "Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10" @default.
- Q90593938 type Item @default.
- Q90593938 label "Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10" @default.
- Q90593938 label "Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10" @default.
- Q90593938 prefLabel "Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10" @default.
- Q90593938 prefLabel "Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10" @default.
- Q90593938 P1433 Q90593938-22961D72-FD7A-4F00-8051-1C53CAE9C48F @default.
- Q90593938 P1476 Q90593938-4237E7E4-4204-48CA-B12B-5497FEDDA530 @default.
- Q90593938 P2093 Q90593938-065038E3-90FD-43D5-B2C8-4835A26FF066 @default.
- Q90593938 P2093 Q90593938-12CBD378-A52D-4477-A445-E8F536DCA1AE @default.
- Q90593938 P2093 Q90593938-2C38DFFA-3B22-40F7-AEB9-4894EE3816EF @default.
- Q90593938 P2093 Q90593938-540E54AD-3E6F-4F7A-AB23-501D7D717BEA @default.
- Q90593938 P2093 Q90593938-56C06E73-D252-464C-8AC2-E1BC9D6E0605 @default.
- Q90593938 P2093 Q90593938-7B504CAC-1D2D-4302-B42F-C028F6A057FE @default.
- Q90593938 P2093 Q90593938-8603032C-3AF2-49C1-8DBD-25DC4F2B1879 @default.
- Q90593938 P2093 Q90593938-8DA42061-9044-42F4-9D4E-DF7D401E11AB @default.
- Q90593938 P2093 Q90593938-9362F582-B43F-4D4E-BD88-D4E34526A320 @default.
- Q90593938 P2093 Q90593938-A20F9591-ED10-4A1C-B842-6FDBEE313DF4 @default.
- Q90593938 P2093 Q90593938-A363AEE9-DD29-4AAE-AD51-74A21FA40FF3 @default.
- Q90593938 P2093 Q90593938-B6457609-DD44-48FB-AF83-73500FD64646 @default.
- Q90593938 P2093 Q90593938-BFE6D41B-A124-41A5-929B-E1F94C76548D @default.
- Q90593938 P2093 Q90593938-E8999371-24B0-4FEA-8CF2-34972D2D3F6B @default.
- Q90593938 P2093 Q90593938-EBBD0182-D07C-45DE-B339-17C735C00B06 @default.
- Q90593938 P304 Q90593938-E102D32B-8807-4AE6-98E9-236237387485 @default.
- Q90593938 P31 Q90593938-8D3FB3C9-FA6A-4435-82F8-70A7671D1F6D @default.
- Q90593938 P356 Q90593938-AD98AC33-33BF-4978-AF2B-469CA634E5D2 @default.
- Q90593938 P433 Q90593938-F5241C23-F68C-41D0-A27A-67248D48E775 @default.
- Q90593938 P478 Q90593938-0C310247-28E9-46F4-9F5A-1AEE41555F59 @default.
- Q90593938 P50 Q90593938-312B8472-897C-4BF4-8577-E50F928ED8B9 @default.
- Q90593938 P50 Q90593938-B71766D5-0A92-45AE-A1F1-2DB8343E65DF @default.
- Q90593938 P577 Q90593938-B7B4C03D-D12C-4719-99B7-B7182628EBC3 @default.
- Q90593938 P698 Q90593938-102B6522-5FED-4D77-96C1-D1AA6F9D8413 @default.
- Q90593938 P921 Q90593938-A2EF8A48-C3E9-47D7-A8E6-ADD9717DB640 @default.
- Q90593938 P921 Q90593938-D544AE4F-A738-47C2-8FE8-478390F85082 @default.
- Q90593938 P921 Q90593938-D6EFCC5A-1353-4054-8B5C-75F0BE4CEA03 @default.
- Q90593938 P921 Q90593938-E782E3E6-CBB2-4E6D-85EB-6DD223B2F56B @default.
- Q90593938 P921 Q90593938-FCF9C792-D27D-414E-8F52-12FDDC82DC51 @default.
- Q90593938 P356 J.JGO.2018.11.011 @default.
- Q90593938 P698 30559073 @default.
- Q90593938 P1433 Q15817005 @default.
- Q90593938 P1476 "Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10" @default.
- Q90593938 P2093 "Alessandro Lugli" @default.
- Q90593938 P2093 "Christiane Andrieu" @default.
- Q90593938 P2093 "Daniel Dietrich" @default.
- Q90593938 P2093 "Daniel Helbling" @default.
- Q90593938 P2093 "Daniel Horber" @default.
- Q90593938 P2093 "Daniela Baertschi" @default.
- Q90593938 P2093 "Dieter Koeberle" @default.
- Q90593938 P2093 "Dirk L Kienle" @default.
- Q90593938 P2093 "Juerg Bernhard" @default.
- Q90593938 P2093 "Luca Quagliata" @default.
- Q90593938 P2093 "Marc Kueng" @default.
- Q90593938 P2093 "Piercarlo Saletti" @default.
- Q90593938 P2093 "Ralph C Winterhalder" @default.
- Q90593938 P2093 "Roger von Moos" @default.
- Q90593938 P2093 "Sara Bastian" @default.
- Q90593938 P304 "304-310" @default.
- Q90593938 P31 Q13442814 @default.
- Q90593938 P356 "10.1016/J.JGO.2018.11.011" @default.
- Q90593938 P433 "2" @default.
- Q90593938 P478 "10" @default.
- Q90593938 P50 Q37831473 @default.
- Q90593938 P50 Q88359356 @default.
- Q90593938 P577 "2018-12-14T00:00:00Z" @default.
- Q90593938 P698 "30559073" @default.
- Q90593938 P921 Q188874 @default.
- Q90593938 P921 Q420207 @default.
- Q90593938 P921 Q420296 @default.
- Q90593938 P921 Q42824440 @default.
- Q90593938 P921 Q6934595 @default.